A Microfluidic System for Investigation of Extravascular Transport and Cellular Uptake of Drugs in Tumors
Overview
Authors
Affiliations
Three-dimensional (3D) tumor models have been established in various microfluidic systems for drug delivery and resistance studies in vitro. However, one of the main drawbacks of these models is non-uniform distribution of cells, leaving regions with very low cell density within the 3D structures. As a result, molecular diffusion in the cell compartments is faster than that observed in solid tumors. To solve this problem, we developed a new technique for preparation of 3D tumor models in vitro. It was based on a microfluidic device containing three parallel channels separated by narrowly spaced posts. Tumor cells were loaded into the central channel at high density. To test the system, B16.F10 melanoma cells were perfusion-cultured overnight and the resulting 3D structure was characterized in terms of viability, density, and morphology of cells as well as transport properties of small fluorescent molecules. Immediately upon loading of tumor cells, the cell density was comparable to those observed in B16.F10 tumor tissues in vivo; and the viability of tumor cells was maintained through the overnight culture. The tumor model displayed low extracellular space and high resistance to diffusion of small molecules. For membrane-permeant molecules (e.g., Hoechst 33342), the rate of interstitial penetration was extremely slow, compared to membrane-impermeant molecules (e.g., sodium fluorescein). This versatile tumor model could be applied to in vitro studies of transport and cellular uptake of drugs and genes.
Lung carcinoma spheroids embedded in a microfluidic platform.
Yildiz-Ozturk E, Saglam-Metiner P, Yesil-Celiktas O Cytotechnology. 2021; 73(3):457-471.
PMID: 34149177 PMC: 8167023. DOI: 10.1007/s10616-021-00470-7.
Jain A, Sharma T, Kumar R, Katare O, Singh B Drug Deliv Transl Res. 2021; 12(5):1136-1160.
PMID: 33966178 DOI: 10.1007/s13346-021-00990-x.
Nomoto T, Inoue Y, Yao Y, Suzuki M, Kanamori K, Takemoto H Sci Adv. 2020; 6(4):eaaz1722.
PMID: 32010792 PMC: 6976296. DOI: 10.1126/sciadv.aaz1722.
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy.
Pradhan S, Smith A, Garson C, Hassani I, Seeto W, Pant K Sci Rep. 2018; 8(1):3171.
PMID: 29453454 PMC: 5816595. DOI: 10.1038/s41598-018-21075-9.
Ozcelikkale A, Moon H, Linnes M, Han B Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017; 9(5).
PMID: 28198106 PMC: 5555839. DOI: 10.1002/wnan.1460.